Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:39 AM
Ignite Modification Date:
2025-12-25 @ 12:39 AM
NCT ID:
NCT00499967
Eligibility Criteria:
Inclusion Criteria:
* Have 2 or more genital warts of prespecified sizes on external surfaces of the body.
* If HIV positive, have HIV RNA \< 400 copies/mL, CD4 count of ≥ 400 cells/mm3, and be taking a triple combination antiviral medication regimen
Exclusion Criteria:
* Prior genital wart treatment within 8 weeks
* Pregnancy or breast-feeding
* Presence of broken or non-intact skin near the wart site or other skin disease at the wart site (e.g., herpes genitalis)
* Treatment with systemic steroids, systemic immunomodulators, immunosuppressants, or chemotherapeutic agents within 3 months
* Current or prior diagnosis of Bowenoid papulosis, cancer, or pre-cancerous tissue in the genital area
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
50 Years
Study:
NCT00499967
Study Brief:
Protocol Section:
NCT00499967